AzTrials
AzTrials

Identify Existing GapsNCT07899437

Code Blue: Status and Barriers in Egypt.

An observational study of Identify Existing Gaps and Code Blue Systems Organization and Implementation Remain Heterogeneous, and no National Data Are Available on Their Current Status, run by National Hepatology & Tropical Medicine Research Institute at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In Egypt, Code Blue systems have been introduced in many healthcare institutions; however, their organization and implementation remain heterogeneous, and no national data are available regarding their current status, operational characteristics, quality monitoring, or implementation barriers. Read more about this study

Who is it for?
Ages 18 years and older
How many people
110 participants
Where
1 siteEgypt
Study dates
8 Sep 2026to 15 Sep 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The target population consists of healthcare professionals aged >18 years old directly involved in the organization, management, supervision, or operation of Code Blue systems within their institutions. Eligible respondents include: * Intensive Care physicians * Emergency physicians * Anesthesiologists * Cardiologists * Internal medicine physicians * Nursing supervisors * Hospital administrators * Quality officers * Department heads

Who may be able to join

  • Healthcare professionals who:
  • Are currently employed in an Egyptian hospital providing inpatient care.
  • Have direct knowledge of the hospital's Code Blue system.
  • Have worked at the institution for at least six months.
  • Provide electronic informed consent.

Who cannot join

  • Healthcare workers without knowledge of the institutional Code Blue system.
  • Duplicate responses from the same hospital (the most complete response will be retained).
  • Hospitals without inpatient services.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • NHTMRI

    Cairo, 11741

Other trials in Egypt

About this study

Official title: Current Status, Structure, and Barriers to Implementation of the Code Blue System in Egyptian Hospitals: A National Cross-sectional Survey

In Egypt, Code Blue systems have been introduced in many healthcare institutions; however, their organization and implementation remain heterogeneous, and no national data are available regarding their current status, operational characteristics, quality monitoring, or implementation barriers. A comprehensive national assessment is therefore needed to identify existing gaps, benchmark current practices against international recommendations, and guide future quality improvement initiatives.

Read the detailed description

This study is a national multicenter cross-sectional survey designed to evaluate the current implementation, organization, resources, and perceived effectiveness of Code Blue systems in Egyptian hospitals.

An electronic questionnaire will be distributed nationwide through professional medical societies, hospital administrations, intensive care networks, emergency medicine societies, nursing associations, and professional social media platforms.

Questionnaire items include multiple-choice questions, dichotomous (Yes/No) responses, Likert-scale ratings, and open-ended questions. The estimated completion time is approximately 7-10minutes.

To ensure equitable contribution from participating hospitals and to minimize potential clustering or overrepresentation of responses from hospitals with larger numbers of healthcare personnel, the number of eligible respondents contributing to the survey from each hospital will be limited to a maximum of 10 participants per hospital. Eligible participants will be selected from healthcare professionals directly involved in or familiar with the Code Blue system, including physicians and nursing staff. This approach will ensure that no single hospital disproportionately influences the overall findings while allowing representation of different professional perspectives within each institution. If more than 10 eligible healthcare professionals from the same hospital are willing to participate, recruitment will be capped at 10 respondents.

Keywords
Code blue, Cardiopulmonary resuscitation (CPR), Basic life support (BLS), Advanced life support (ALS)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Perceived effectiveness

    Perceived overall effectiveness of the Code Blue system

    Measured: immediately after the survey completion

Secondary outcomes (7)
  1. Availability and organizational characteristics of Code Blue systems

    by asking about the presence and duration of the implementation of the code blue system in the hospital

    Measured: immediately after the survey completion

  2. Code Blue team structure and readiness

    by asking about the 24/7 availability of trained, competent team

    Measured: immediately at the time of the survey

  3. Training and preparedness of Code Blue personnel

    By asking about mandatory BLS/ALS training

    Measured: immediately after the survey completion

  4. Documentation, auditing

    by asking about the documentation of Code Blue events and recording of response time, survival to discharge, and neurological outcomes, as well as post-event debriefing and regular case auditing.

    Measured: immediately at the time of the survey

  5. Monitoring of quality indicators

    by asking about response time, time to first defibrillation, CPR quality, ROSC, survival to discharge, and neurological outcomes.

    Measured: immediately at the time of the survey

  6. Barriers against effective implementation

    By asking about the presence of staffing, training, communication, delayed response, equipment availability, hospital support, funding, workload, and the presence of written policies.

    Measured: immediately after the survey completion

  7. Healthcare professionals' recommendations for strengthening

    by asking about the best choice (one/or more); national guidelines, mandatory BLS/ALS certification, a national Code Blue registry, digital reporting, mandatory mock codes, and national accreditation standards.

    Measured: immediately after the survey completion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Oct 2026
  2. Study start8 Sep 2026
  3. Primary completion15 Sep 2026
  4. Study completion15 Sep 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
110 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07899437
Sponsor's protocol ID
Code Blue system
Status last verified
Sep 2026
First submitted
3 Oct 2026
Last updated
27 Oct 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Individual participant data (IPD) will not be made publicly available because the dataset contains potentially identifiable information related to participating healthcare professionals and hospitals. De-identified data may be made available from the corresponding author upon reasonable request, subject to ethical and institutional approval and applicable data-protection requirements.

Publications

  • 7. Nuryana A, et al. Barriers to Implementing the Code Blue System in Hospitals: A Scoping Review. Journal of Nursing Practice. 2024.

  • Biskin Cetin S, Sezgin MG, Coskun M, Sari F, Boztug N. Evaluation of Code Blue Notifications and Their Results: A University Hospital Example. Turk J Anaesthesiol Reanim. 2023 Apr;51(2):105-111. doi: 10.5152/TJAR.2023.22965.

    PubMed 37140575
  • Nolan JP, Berg RA, Andersen LW, Bhanji F, Chan PS, Donnino MW, Lim SH, Ma MH, Nadkarni VM, Starks MA, Perkins GD, Morley PT, Soar J; Utstein Collaborators. Cardiac Arrest and Cardiopulmonary Resuscitation Outcome Reports: Update of the Utstein Resuscitation Registry Template for In-Hospital Cardiac Arrest: A Consensus Report From a Task Force of the International Liaison Committee on Resuscitation (American Heart Association, European Resuscitation Council, Australian and New Zealand Council on Resuscitation, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Southern Africa, Resuscitation Council of Asia). Resuscitation. 2019 Nov;144:166-177. doi: 10.1016/j.resuscitation.2019.08.021. Epub 2019 Sep 16.

    PubMed 31536777

Questions about this trial

What is this clinical trial studying?

An observational study of Identify Existing Gaps and Code Blue Systems Organization and Implementation Remain Heterogeneous, and no National Data Are Available on Their Current Status, run by National Hepatology & Tropical Medicine Research Institute at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Perceived effectiveness (time frame: immediately after the survey completion). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07899437, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in